-
CarTrade Tech
Baseless valuation for a `fatherless-motherless’ company with an accumulated deficit of more than four times its equity capital!
-
Krsnaa Diagnostics
Promoter’s low equity stake makes the valuation skeptical
-
Devyani International
Promoters selling part of their stake after filing the Red Herring Prospectus makes mockery of IPO regulation
-
Windlas Biotech
Promoters’ vacillating corporate policies and penchant for related party transactions make it below investible grade.
-
Rolex Rings
Fluctuating performance, poor capacity utilization, steep valuation, past loan defaults, CDR restrictions, non-dividend paying track, pledged promoters’ stake, family-dominated management, etc., take the gleam away
-
Glenmark Life Sciences
History repeating itself? Generics in 2009 and Life Sciences in 2021!
-
Tatva Chintan
Strong Fundamentals versus Steep Valuation…
-
Zomato
Loss-making `fatherless-motherless’ company, unabated negative operating cash flow, bulging accumulated loss (over Rs 5600 cr), deploying huge (Rs 9000 cr)…
-
Clean Science
`Clean’ fundamentals may deserve steep valuation though existing shareholders’ negative cost of residual holding is cause for worry, post lock-in period…
-
G R Infraprojects
Notwithstanding impressive financials, changing registered office five times, taking properties on lease from promoters’ relatives,..